| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.098 | 0.04 |